http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_adffbc64a8ac9fef9c6aa2f088f2eff6
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Yu |
| name | Dihua Yu |
| given-name | Dihua |
| organization-name | 1Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 2The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. 1Departments of Surgical Oncology and Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center and; 2The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas 1Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas and 2Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland Authors' Affiliations: Departments of 1Molecular and Cellular Oncology, 2Neurosurgery, and 3Pathology, The University of Texas MD Anderson Cancer Center; 4Cancer Biology Program, Graduate School of Biomedical Sciences-Houston, Houston, Texas; 5Women's Cancers Section, Laboratory of Molecular Pharmacology, National Cancer Institute, Bethesda, Maryland; and 6Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana; Authors' Affiliations: Departments of 1Molecular and Cellular Oncology, 2Neurosurgery, and 3Pathology, The University of Texas MD Anderson Cancer Center; 4Cancer Biology Program, Graduate School of Biomedical Sciences-Houston, Houston, Texas; 5Women's Cancers Section, Laboratory of Molecular Pharmacology, National Cancer Institute, Bethesda, Maryland; and 6Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana 1Molecular and Cellular Oncology, Departments of Department of Tumor Biology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030 Department of Molecular and Cellular Oncology The Univ. Texas MD Anderson Cancer Center, Houston, Texas, USA Cancer Biology Program, The University of Texas MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences Houston, Texas, USA. 1Surgical Oncology and Departments of Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 1Surgical Oncology and Departments of; 2Molecular and Cellular Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 1Departments of Surgical Oncology, 8Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; and 2Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 3MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas.; 7Center for Molecular Medicine, China Medical University, Taichung, Taiwan. Center for Molecular Medicine, China Medical UniversityTaichung 40402, Taiwan. 4Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Authors' Affiliation: Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas Authors' Affiliations: 1Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston; 2Cancer Biology Program, University of Texas Graduate School of Biomedical Sciences-Houston, Houston; 3Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas; 4Department of Computational Biology and Bioinformatics, F. Hoffmann-La-Roche AG, Basel, Switzerland; and 5Molecular Oncology Group, McGill University Health Center, Montreal, Quebec, Canada; Authors' Affiliations: 1Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston; 2Cancer Biology Program, University of Texas Graduate School of Biomedical Sciences-Houston, Houston; 3Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas; 4Department of Computational Biology and Bioinformatics, F. Hoffmann-La-Roche AG, Basel, Switzerland; and 5Molecular Oncology Group, McGill University Health Center, Montreal, Quebec, Canada Authors' Affiliations: 1Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center; and 2Cancer Biology Program, The University of Texas Health Science Center at Houston Graduate School of Biomedical Sciences, Houston, Texas; Authors' Affiliations: 1Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center; and 2Cancer Biology Program, The University of Texas Health Science Center at Houston Graduate School of Biomedical Sciences, Houston, Texas 1Surgical Oncology, Departments of; 4The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 6MD Anderson Cancer Center, Houston, Texas; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX 77030, USA. Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Cancer Biology Program, Graduate School of Biomedical Sciences at Houston, Houston, TX 77030, USA 1Surgical Oncology, Departments of Authors' Affiliations: 1Duke University Medical Center, Durham, North Carolina; 2George Mason University, Center for Applied Proteomics and Molecular Medicine, Manassas, Virginia; 3Texas A&M Health Sciences Center, College of Medicine, Round Rock; and 4MD Anderson Cancer Center, Houston, Texas Authors' Affiliations: 1Departments of Molecular and Cellular Oncology, and 2Systems Biology, The University of Texas MD Anderson Cancer Center; 3Graduate School of Biomedical Sciences, The University of Texas, Houston, Texas; 4Department of Medicine and Biochemistry, McGill University, Montreal, Quebec, Canada; 5China Medical University Hospital; and 6Asia University, Taichung, Taiwan; Authors' Affiliations: 1Departments of Molecular and Cellular Oncology, and 2Systems Biology, The University of Texas MD Anderson Cancer Center; 3Graduate School of Biomedical Sciences, The University of Texas, Houston, Texas; 4Department of Medicine and Biochemistry, McGill University, Montreal, Quebec, Canada; 5China Medical University Hospital; and 6Asia University, Taichung, Taiwan Department of Molecular & Cellular Oncology, The University of Texas MD Anderson Cancer CenterHouston, Texas 77030, USA. Phuong K. Morrow, Joe Ensor, Daniel J. Booser, Julia A. Moore, Peter R. Flores, Yan Xiong, Siyuan Zhang, Aysegul A. Sahin, Rodolfo Nuñez, Gabriel N. Hortobagyi, Dihua Yu, Francisco J. Esteva, The University of Texas MD Anderson Cancer Center, Houston, TX; Gerburg M. Wulf, Jeanna Coviello, Beth Israel Deaconess Medical Center; Ian E. Krop, Eric P. Winer, Dana-Farber Cancer Institute; David W. Kindelberger, Brigham and Women's Hospital, Boston, MA. Authors' Affiliations: Departments of 1Molecular and Cellular Oncology and 2Breast Medical Oncology, The University of Texas MD Anderson Cancer Center; 3Cancer Biology Program, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas; 4Department of Oncology, the Sidney Kimmel Cancer Center at Johns Hopkins and the Viragh Pancreatic Cancer Center, Baltimore, Maryland; 5Department of Immunology, School of Medicine, Shanghai Jiaotong University, Shanghai, China; and 6Goodman Cancer Center, McGill University, Montreal, Quebec, Canada; Authors' Affiliations: Departments of 1Molecular and Cellular Oncology and 2Breast Medical Oncology, The University of Texas MD Anderson Cancer Center; 3Cancer Biology Program, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas; 4Department of Oncology, the Sidney Kimmel Cancer Center at Johns Hopkins and the Viragh Pancreatic Cancer Center, Baltimore, Maryland; 5Department of Immunology, School of Medicine, Shanghai Jiaotong University, Shanghai, China; and 6Goodman Cancer Center, McGill University, Montreal, Quebec, Canada 1Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.; 2Cancer Biology Program, University of Texas Graduate School of Biomedical Sciences – Houston, Houston, Texas.; 6Center for Molecular Medicine, China Medical University, Taichung, Taiwan. 1Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 5Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 7Center for Molecular Medicine, China Medical University, Taichung, Taiwan. Authors' Affiliations: 1Department of Medicine, Section of Hematology and Medical Oncology, 2Department of Pharmacology, 3Center for Bioenvironmental Research, and 4Department of Pulmonary Diseases Critical Care and Environmental Medicine, Tulane University Health Sciences Center; and 5Department of Pharmacology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; 6Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee and Department of Veterans Affairs, Nashville, Tennessee; 7Department of Molecular and Cellular Oncology, University of Texas M.D. Anderson Cancer Center; and 8Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas; 9Johnson & Johnson Pharmaceutical Research and Development, Raritan, New Jersey; 10Department of Pathology, Section on Comparative Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina; 11Department of Medical Sciences, Indiana University, School of Medicine, Bloomingto 1Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center; Dept. of Surgical Oncology, Unit 107 The University of Texas M. D. Anderson Cancer Center Houston, TX 77030, USA Department of Gynecologic Oncology, Surgical Oncology, Breast Medical Oncology and Immunology, M. D. Anderson Cancer Center, Houston, Texas 77030 1Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 2Cancer Biology Program, The University of Texas MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, Houston, Texas. 4Surgical Oncology, and |
Incoming Links
Total number of triples: 194.